General MedicationsORALStandard
PARICALCITOL
PARICALCITOL
Standard Dose
1MCG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview PARICALCITOL is listed in Drugs@FDA under application 207672 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient PARICALCITOL Form and strength CAPSULE;ORAL - 1MCG Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2016-01-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview PARICALCITOL is listed in Drugs@FDA under application 207672 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PARICALCITOL Form and strength CAPSULE;ORAL - 1MCG Sponsor AUROBINDO PHARMA LTD Submission history Latest submission status date: 2016-01-14 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.